BerganKDV Wealth Management LLC Has $13.01 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

BerganKDV Wealth Management LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 1.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,338 shares of the healthcare conglomerate’s stock after selling 458 shares during the period. UnitedHealth Group accounts for about 1.5% of BerganKDV Wealth Management LLC’s portfolio, making the stock its 16th biggest holding. BerganKDV Wealth Management LLC’s holdings in UnitedHealth Group were worth $13,014,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Signature Estate & Investment Advisors LLC lifted its position in UnitedHealth Group by 1.2% in the 1st quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the healthcare conglomerate’s stock valued at $820,000 after acquiring an additional 19 shares in the last quarter. Steph & Co. lifted its position in UnitedHealth Group by 1.6% in the 1st quarter. Steph & Co. now owns 1,290 shares of the healthcare conglomerate’s stock valued at $658,000 after acquiring an additional 20 shares in the last quarter. First City Capital Management Inc. lifted its position in UnitedHealth Group by 1.5% in the 1st quarter. First City Capital Management Inc. now owns 1,350 shares of the healthcare conglomerate’s stock valued at $688,000 after acquiring an additional 20 shares in the last quarter. Griffin Asset Management Inc. lifted its holdings in shares of UnitedHealth Group by 0.3% during the 1st quarter. Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock valued at $3,414,000 after buying an additional 21 shares during the period. Finally, Physicians Financial Services Inc. lifted its holdings in shares of UnitedHealth Group by 5.2% during the 1st quarter. Physicians Financial Services Inc. now owns 424 shares of the healthcare conglomerate’s stock valued at $216,000 after buying an additional 21 shares during the period. Institutional investors and hedge funds own 87.25% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 99,312 shares of UnitedHealth Group stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total value of $53,059,422.24. Following the completion of the transaction, the director now owns 787,372 shares of the company’s stock, valued at $420,669,238.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Stephen J. Hemsley sold 99,312 shares of the business’s stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the completion of the sale, the director now owns 787,372 shares of the company’s stock, valued at $420,669,238.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO John F. Rex sold 13,183 shares of the business’s stock in a transaction dated Friday, July 29th. The stock was sold at an average price of $541.53, for a total transaction of $7,138,989.99. Following the sale, the chief financial officer now directly owns 141,508 shares of the company’s stock, valued at approximately $76,630,827.24. The disclosure for this sale can be found here. Over the last quarter, insiders sold 139,051 shares of company stock valued at $74,450,958. Corporate insiders own 0.40% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Sanford C. Bernstein cut UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price target on the stock. in a report on Thursday, May 26th. They noted that the move was a valuation call. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a report on Thursday, September 8th. Credit Suisse Group increased their price target on UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a report on Monday, July 18th. Oppenheimer upped their price objective on UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Finally, BMO Capital Markets increased their price objective on shares of UnitedHealth Group from $600.00 to $610.00 in a report on Wednesday, July 20th. Three research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $586.40.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $517.46 on Friday. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29. The company’s 50 day moving average is $530.11 and its 200 day moving average is $512.45. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. The firm has a market cap of $484.02 billion, a price-to-earnings ratio of 27.02, a PEG ratio of 1.61 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. The company had revenue of $80.33 billion during the quarter, compared to the consensus estimate of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The firm’s quarterly revenue was up 12.6% on a year-over-year basis. During the same period in the previous year, the firm posted $4.70 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were issued a $1.65 dividend. The ex-dividend date was Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a yield of 1.28%. UnitedHealth Group’s payout ratio is 34.46%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.